Vilanova Joan C, Barceló Joaquim
Department of Magnetic Resonance, Clínica Girona, Lorenzana, 36, 17002 Girona, Spain.
Abdom Imaging. 2007 Mar-Apr;32(2):253-61. doi: 10.1007/s00261-007-9191-7.
Magnetic resonance spectroscopic imaging (MRSI) represents a noninvasive technique to extend the diagnostic evaluation of prostatic cancer, beyond the morphologic information provided by MR imaging throughout the detection of cellular metabolites (choline and citrate). MRSI combined with the anatomical information provided by MRI can improve the assessment cancer location and extent within the prostate, extracapsular spread and cancer aggressiveness; both before and after treatment. We review the performance of MRI with MRSI and the role in the detection, localization, staging and management of the patient pre- and posttherapy for prostate cancer.
磁共振波谱成像（MRSI）是一种非侵入性技术，可通过检测细胞代谢物（胆碱和柠檬酸盐），在磁共振成像提供的形态学信息之外，扩展对前列腺癌的诊断评估。MRSI与MRI提供的解剖学信息相结合，可以改善对前列腺内癌症位置和范围、包膜外扩散以及癌症侵袭性的评估；在治疗前后均可进行评估。我们回顾了MRI联合MRSI的性能以及在前列腺癌患者治疗前和治疗后检测、定位、分期和管理中的作用。
